Cancer, aging and cellular senescence - PubMed (original) (raw)
Review
. 2000 Jan-Feb;14(1):183-8.
Affiliations
- PMID: 10757076
Review
Cancer, aging and cellular senescence
J Campisi. In Vivo. 2000 Jan-Feb.
Abstract
Normal cells do not divide indefinitely due to a process termed cellular or replicative senescence. Several lines of evidence suggest that replicative senescence evolved to protect higher eukaryotes, particularly mammals, from developing cancer. Senescent cells differ from their presenescent counterparts in three way: 1) they arrest growth and cannot be stimulated to reenter the cell cycle by physiological mitogens; 2) they become resistant to apoptotic cell death; 3) they acquire altered differentiated functions. Replicative senescence occurs because, owing to the biochemistry of DNA replication, cells acquire one or more critically short telomere. The mechanism by which a short telomere induces the senescent phenotype is unknown. Recent findings suggest that certain types of DNA damage and inappropriate mitogenic signals can also cause cells to adopt a senescent phenotype. Thus, cells respond to a number of potentially oncogenic stimuli by adopting a senescent phenotype. These findings suggest that the senescence response is a fail-safe mechanism that protects cells from tumorigenic transformation. Despite the protection from cancer conveyed by cellular senescence and other mechanisms that suppress tumorigenesis, the development of cancer is almost inevitable as mammalian organisms age. Why is this the case? Certainly, aging predisposes cells to accumulate mutations, several of which are necessary before malignant transformation occurs, particularly in humans. However, many benign or relatively well-controlled tumors may also harbor many potentially oncogenic mutations, suggesting that the tissue microenvironment can suppress the expression of many malignant phenotypes. Although the idea remains controversial, cellular senescence has also been proposed to contribute to organismal aging. Senescent cells have recently been shown to accumulate with age in human tissues. One possibility is that the tissue microenvironment is disrupted by the accumulation of dysfunctional senescent cells. Thus, mutation accumulation may synergize with the accumulation of senescent cells, leading to increasing risk for developing cancer that is a hallmark of mammalian aging.
Similar articles
- The biology of replicative senescence.
Campisi J. Campisi J. Eur J Cancer. 1997 Apr;33(5):703-9. doi: 10.1016/S0959-8049(96)00058-5. Eur J Cancer. 1997. PMID: 9282108 Review. - Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors.
Campisi J. Campisi J. Cell. 2005 Feb 25;120(4):513-22. doi: 10.1016/j.cell.2005.02.003. Cell. 2005. PMID: 15734683 Review. - Acquisition of oxidative DNA damage during senescence: the first step toward carcinogenesis?
Martien S, Abbadie C. Martien S, et al. Ann N Y Acad Sci. 2007 Nov;1119:51-63. doi: 10.1196/annals.1404.010. Ann N Y Acad Sci. 2007. PMID: 18056954 Review. - Mitochondria damage checkpoint, aging, and cancer.
Singh KK. Singh KK. Ann N Y Acad Sci. 2006 May;1067:182-90. doi: 10.1196/annals.1354.022. Ann N Y Acad Sci. 2006. PMID: 16803984 Review.
Cited by
- Senescent cells promote breast cancer cells motility by secreting GM-CSF and bFGF that activate the JNK signaling pathway.
Wang N, Fang Y, Hou Y, Cheng D, Dressler EV, Wang H, Wang J, Wang G, Li Y, Liu H, Xiang R, Yang S, Sun P. Wang N, et al. Cell Commun Signal. 2024 Oct 7;22(1):478. doi: 10.1186/s12964-024-01861-x. Cell Commun Signal. 2024. PMID: 39375718 Free PMC article. - Computational identification of natural senotherapeutic compounds that mimic dasatinib based on gene expression data.
Meiners F, Hinz B, Boeckmann L, Secci R, Sueto S, Kuepfer L, Fuellen G, Barrantes I. Meiners F, et al. Sci Rep. 2024 Mar 15;14(1):6286. doi: 10.1038/s41598-024-55870-4. Sci Rep. 2024. PMID: 38491064 Free PMC article. - Biomarkers of UVB radiation-related senescent fibroblasts.
Qiang M, Dai Z. Qiang M, et al. Sci Rep. 2024 Jan 9;14(1):933. doi: 10.1038/s41598-023-51058-4. Sci Rep. 2024. PMID: 38195709 Free PMC article. - Reappraisal of the Concept of Accelerated Aging in Neurodegeneration and Beyond.
Statsenko Y, Kuznetsov NV, Morozova D, Liaonchyk K, Simiyu GL, Smetanina D, Kashapov A, Meribout S, Gorkom KN, Hamoudi R, Ismail F, Ansari SA, Emerald BS, Ljubisavljevic M. Statsenko Y, et al. Cells. 2023 Oct 14;12(20):2451. doi: 10.3390/cells12202451. Cells. 2023. PMID: 37887295 Free PMC article. Review. - Senescence program and its reprogramming in pancreatic premalignancy.
Yang K, Li X, Xie K. Yang K, et al. Cell Death Dis. 2023 Aug 17;14(8):528. doi: 10.1038/s41419-023-06040-3. Cell Death Dis. 2023. PMID: 37591827 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical